3 years ago

ExSeed Health Raises €2.9 Million to Expand Male Fertility Testing

  • ExSeed Health, a London-based startup focused on male fertility testing, has secured €2.9 million in a seed extension round led by Ascension

  • The funding will be used to drive further European expansion and tackle the growing problem of male infertility

  • ExSeed's at-home kit combines cloud-based analysis with smartphone capabilities, providing patients with a live view of their sperm sample and highly accurate quantitative analysis of their sperm concentration and motility

  • The results are paired with additional behavioral and diet data to generate a bespoke lifestyle program that helps would-be dads improve their sperm quality over a 90-day period

  • ExSeed's device has been clinically validated as an in vitro diagnostic medical device by the British Standards Institute (BSI) and has received CE certification, guaranteeing patients over 95% accuracy.

      • ProblemHealthcare

      "Infertility affects millions of men globally, yet societal stigma prevents open discussion and early intervention. Traditional clinic-based testing is often inconvenient, expensive, and can be a barrier to seeking help."

      Solution

      "ExSeed offers a discreet, affordable, and clinically-validated at-home male fertility testing kit. Using a smartphone and their advanced technology, men can analyze their sperm concentration and motility in minutes. The accompanying app provides personalized lifestyle improvement plans and facilitates connections with fertility specialists if needed."

      Covered on